Innovations in Cancer Science & Clinical Therapeutics

“Innovations in Cancer Science & Clinical Therapeutics” is an international, peer-reviewed, open-access journal that publishes original research articles, review articles, and case reports related to all aspects of cancer research and clinical therapeutics. The journal aims to provide a platform for researchers, clinicians, and practitioners to share their knowledge and ideas, and to facilitate the advancement of cancer research and treatment.

Access policy: Open access
Review policy: Double-blind peer review
Frequency: Publish continuously

More info

Submit Paper

Early Online

Vol. No. () Early Online

Published: April 24, 2024

Virtual ward: The future in the management of neutropenic sepsis in the NHS

Denis Taiwo, Nnamani N, Ochai A, Adeyinka OO
Abstract views: 38   PDF downloads: 22   HTML downloads: 0   pages: 001-003

About “Innovations in Cancer Science & Clinical Therapeutics”:

“Innovations in Cancer Science & Clinical Therapeutics” is an international, peer-reviewed, open-access journal that publishes original research articles, review articles, and case reports related to all aspects of cancer research and clinical therapeutics. The journal aims to provide a platform for researchers, clinicians, and practitioners to share their knowledge and ideas, and to facilitate the advancement of cancer research and treatment.

The journal covers a wide range of topics in cancer science and clinical therapeutics, including but not limited to:

  • Cancer biology and genetics
  • Cancer prevention, screening, and diagnosis
  • Cancer treatment, including chemotherapy, radiation therapy, immunotherapy, and targeted therapy
  • Supportive care and palliative care for cancer patients
  • Clinical trials and translational research
  • Cancer survivorship and quality of life
  • Cancer epidemiology and public health

Innovations in Cancer Science & Clinical Therapeutics is committed to upholding the highest standards of ethical and scientific rigor in publishing. The journal follows the guidelines of the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE) regarding ethical standards for publishing. All manuscripts are subject to rigorous peer review by experts in the field, and authors are expected to adhere to the highest standards of ethical conduct in their research.

Innovations in Cancer Science & Clinical Therapeutics is an open-access journal, which means that all articles are freely available to readers worldwide. The journal does not charge any publication fees, and authors retain copyright of their published articles. The journal is published on a continuous basis, and articles are published online as soon as they are accepted after peer review.

Our Mission:

Our mission at “Innovations in Cancer Science & Clinical Therapeutics” is to provide a high-quality platform for the publication of cutting-edge research in the field of cancer science and clinical therapeutics. We aim to publish original research, reviews, case reports, and perspectives that can contribute to the advancement of cancer science and the development of new therapies for the benefit of cancer patients worldwide.

Our primary goal is to foster the dissemination of knowledge in the field of cancer research and provide a forum for interdisciplinary discussions among researchers, clinicians, and healthcare professionals. We encourage submissions that address the most pressing issues in cancer research, including the biology of cancer, cancer genetics, cancer immunology, cancer diagnosis and screening, cancer treatment, and the management of cancer-related symptoms and side effects.

We are committed to ensuring the highest standards of ethical and scientific integrity in all published work. We adhere to the guidelines set forth by the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE) to ensure that all published work meets the highest ethical standards. We also comply with the International Association of Scientific, Technical and Medical Publishers (STM) and the Open Access Scholarly Publishers Association (OASPA) guidelines for open access publishing.

Our ultimate mission is to advance the understanding of cancer biology and clinical therapeutics through the dissemination of high-quality research. We believe that this can be achieved by providing a platform for the publication of cutting-edge research in the field of cancer science and clinical therapeutics. We are committed to facilitating the translation of basic science research into clinical practice and to promoting the development of new cancer therapies that can improve the lives of cancer patients.

In pursuit of this mission, we are dedicated to providing a fair and efficient peer-review process, ensuring that all manuscripts are evaluated based on their scientific merit, novelty, and potential impact. We strive to provide authors with constructive feedback to help improve the quality of their work and to make the publication process as smooth and efficient as possible.

Overall, our mission is to advance the understanding of cancer science and clinical therapeutics and to facilitate the development of new therapies for the benefit of cancer patients worldwide. We are committed to achieving this through the publication of high-quality research and the promotion of interdisciplinary discussions among researchers, clinicians, and healthcare professionals.

Our Vision:

At Innovations in Cancer Science & Clinical Therapeutics, we envision becoming a leading international open-access journal in the field of cancer research and clinical therapeutics. Our mission is to provide a platform for high-quality research that explores the latest advances in cancer science and clinical practice. We believe that by sharing innovative ideas and breakthrough discoveries, we can accelerate the development of new treatments and improve patient outcomes.

Our journal aims to foster collaboration and interdisciplinary dialogue between researchers, clinicians, and other healthcare professionals, encouraging the translation of scientific discoveries into clinical practice. Our vision is to be the go-to source for cancer-related research, offering a comprehensive range of articles that appeal to a broad audience, from basic scientists to clinical practitioners and policy-makers.

We aim to achieve this vision through several key objectives. First, we strive to publish articles that are scientifically rigorous and impactful, ensuring that our readership stays abreast of the latest research findings. Second, we are committed to promoting diversity and inclusivity in our authorship and editorial board, recognizing that a variety of perspectives can lead to more comprehensive and innovative research. Third, we seek to provide an open-access platform that is accessible to all, regardless of geographical location or financial means. Finally, we aim to cultivate a supportive and collaborative community of researchers and healthcare professionals, encouraging the exchange of ideas and collaboration on innovative projects.

Our vision is to provide a space for researchers and healthcare professionals to come together, share their knowledge and ideas, and advance the field of cancer research and clinical therapeutics. We believe that by breaking down the traditional silos between basic research and clinical practice, we can accelerate the pace of discovery and bring new treatments to patients more quickly. We are committed to fostering a culture of collaboration and innovation, where new ideas are encouraged, and traditional ways of thinking are challenged.

In conclusion, our vision for Innovations in Cancer Science & Clinical Therapeutics is to be a leading open-access journal in the field of cancer research and clinical therapeutics, providing a platform for high-quality research that fosters collaboration and innovation. We believe that by promoting diversity and inclusivity, offering open access to our readership, and cultivating a supportive community, we can accelerate the pace of discovery and bring new treatments to patients more quickly.